Pieris Pharma announces 1-for-80 reverse stock split
| PIRSDelisted Stock | USD 13.60 2.53 15.69% |
Slightly above 62% of Pieris Pharmaceuticals' investor base is looking to short. The analysis of the overall investor sentiment regarding Pieris Pharmaceuticals suggests that many traders are alarmed. Pieris Pharmaceuticals' investing sentiment can be driven by a variety of factors including economic data, Pieris Pharmaceuticals' earnings reports, geopolitical events, and overall market trends.
Pieris |
Pieris Pharma announces 1-for-80 reverse stock split
Read at investing.com
 |
Pieris Pharmaceuticals Fundamental Analysis
We analyze Pieris Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pieris Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pieris Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Probability Of Bankruptcy
Probability Of Bankruptcy Comparative Analysis
Pieris Pharmaceuticals is currently under evaluation in probability of bankruptcy category among its peers. Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
Pieris Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Pieris Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Pieris Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Pieris Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Pieris Pharmaceuticals Related Equities
| PDSB | PDS Biotechnology | 5.43 | ||||
| TERN | Terns Pharmaceuticals | 3.71 | ||||
| LPTX | Leap Therapeutics | 2.03 | ||||
| ADAP | Adaptimmune Therapeutics | 1.72 | ||||
| INZY | Inozyme Pharma | 0.33 | ||||
| AFMD | Affimed NV | 0.93 | ||||
| ACHL | Achilles Therapeutics | 2.94 | ||||
| XFOR | X4 Pharmaceuticals | 2.99 | ||||
| CKPT | Checkpoint Therapeutics | 3.42 | ||||
| ADCT | ADC Therapeutics | 4.55 | ||||
| CRVS | Corvus Pharmaceuticals | 6.50 | ||||
| AGEN | Agenus | 7.21 | ||||
| MREO | Mereo BioPharma | 7.75 | ||||
| CUE | Cue Biopharma | 10.48 |
Check out Pieris Pharmaceuticals Hype Analysis, Pieris Pharmaceuticals Correlation and Pieris Pharmaceuticals Performance. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Consideration for investing in Pieris Stock
If you are still planning to invest in Pieris Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Pieris Pharmaceuticals' history and understand the potential risks before investing.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |